Investment
Features
FeesSafety
Academy
More
Pluang+

Compare C.H. Robinson Worldwide, Inc. (CHRW) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

C.H. Robinson Worldwide, Inc.Trade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

C.H. Robinson Worldwide, Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? C.H. Robinson Worldwide, Inc. trades at $145.4 (market cap $16.96B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 4.8× C.H. Robinson Worldwide, Inc.'s market cap, and C.H. Robinson Worldwide, Inc. pays the higher dividend (1.74%). Which is the better fit depends on your goals.

CHRWREGN
Market Cap
$16.96B$82.06B
Sector
IndustrialsHealth
52-Week High
$209.42$812.27
52-Week Low
$118.77$555.51
Enterprise Value
$18.78B$76.77B
Dividend Yield
1.74%0.47%

Returns comparison

Trailing returns across standard periods

About C.H. Robinson Worldwide, Inc.

C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.

Read more on CHRW

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN